[
  {
    "date": "2023-12-31",
    "symbol": "AFMD",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-36619",
    "entityregistrantname": "AFFIMED N.V.",
    "entityincorporationstatecountrycode": "P7",
    "contactpersonnelname": "Andreas Harstrick",
    "entityaddressaddressline1": "Gottlieb-Daimler-Straβe 2",
    "entityaddresscityortown": "Mannheim",
    "entityaddressstateorprovince": "NY",
    "entityaddresscountry": "DE",
    "entityaddresspostalzipcode": 68165,
    "cityareacode": 49,
    "localphonenumber": "621-56003-0",
    "phonefaxnumberdescription": "212 3446 4900",
    "security12btitle": "Common shares, nominal value €0.1 per",
    "tradingsymbol": "AFMD",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entitycommonstocksharesoutstanding": 15227463.1,
    "entitycentralindexkey": 1608390,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "auditorname": "KPMG AG Wirtschaftsprüfungsgesellschaft",
    "auditorfirmid": 1021,
    "auditorlocation": "Mannheim, Germany",
    "revenue": 8275000,
    "otheroperatingincomeexpense": 4697000,
    "researchanddevelopmentexpense": 94958000,
    "generalandadministrativeexpense": 24675000,
    "profitlossfromoperatingactivities": -106661000,
    "financeincomecost": 726000,
    "profitlossbeforetax": -105935000,
    "incometaxexpensecontinuingoperations": 3000,
    "profitloss": -105938000,
    "comprehensiveincome": -105938000,
    "basicearningslosspershare": -7.09,
    "dilutedearningslosspershare": -7.09,
    "weightedaveragesharesoutstandingbasic": 14939916,
    "weightedaveragesharesoutstandingdiluted": 14939916,
    "intangibleassetsotherthangoodwill": 25000,
    "propertyplantandequipment": 4905000,
    "rightofuseassets": 8039000,
    "noncurrentassets": 12969000,
    "cashandcashequivalents": 38529000,
    "currentinvestments": 33518000,
    "othercurrentfinancialassets": 851000,
    "tradeandothercurrentreceivables": 5327000,
    "inventories": 463000,
    "currentotherassetsandprepaidexpenses": 5500000,
    "currentassets": 84188000,
    "assets": 97157000,
    "issuedcapital": 1500000,
    "capitalreserve": 593666000,
    "otherreserves": -1231000,
    "retainedearnings": -536128000,
    "equity": 57807000,
    "longtermborrowings": 6319000,
    "noncurrentcontractliabilities": 464000,
    "noncurrentleaseliabilities": 6660000,
    "noncurrentliabilities": 13443000,
    "tradeandothercurrentpayables": 18916000,
    "currentborrowingsandcurrentportionofnoncurrentborrowings": 5833000,
    "currentleaseliabilities": 539000,
    "currentcontractliabilities": 619000,
    "currentliabilities": 25907000,
    "equityandliabilities": 97157000,
    "adjustmentsforincometaxexpense": 3000,
    "adjustmentsfordepreciationandamortisationexpense": 1749000,
    "adjustmentsforgainlossondisposalofinvestmentsinsubsidiariesjointventuresandassociates": 4339000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": 82000,
    "adjustmentsforsharebasedpayments": 10714000,
    "adjustmentsforfinanceincomecost": 726000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -98455000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 1093000,
    "adjustmentsfordecreaseincreaseinfinancialassets": -851000,
    "adjustmentsfordecreaseincreaseininventories": 100000,
    "adjustmentsfordecreaseincreaseinotherassetsandprepaidexpenses": -2737000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -9766000,
    "cashflowsfromusedinoperations": -110616000,
    "interestreceivedclassifiedasoperatingactivities": 1743000,
    "interestpaidclassifiedasoperatingactivities": 1393000,
    "incometaxespaidrefundclassifiedasoperatingactivities": 3000,
    "cashflowsfromusedinoperatingactivities": -110269000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 3729000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 938000,
    "purchaseofavailableforsalefinancialassets": 34246000,
    "cashflowsfromlosingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": 978000,
    "cashflowsfromusedininvestingactivities": -36059000,
    "proceedsfromissueofordinaryshares": 235000,
    "paymentsforshareissuecosts": 35000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 491000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 5929000,
    "cashflowsfromusedinfinancingactivities": -6220000,
    "effectofexchangeratechangesoncashandcashequivalents": 791000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -152548000,
    "issueofequity": 7000,
    "increasedecreasethroughsharebasedpaymenttransactions": 10714000,
    "ifrscashcashequivalentsandshortterminvestments": 72000000,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P5Y",
    "titleofnewifrs": "Classification of Liabilities as Current or Non-current and Non-current Liabilities with Covenants (Amendments to IAS 1)",
    "dateasatwhichentityplanstoapplynewifrsinitially": "2024-01-01",
    "percentageofentitysrevenue": 0.1,
    "revenuefromrenderingofservices": 600000,
    "revenuethatwasincludedincontractliabilitybalanceatbeginningofperiod": 1100000,
    "thresholdamounteligibletoreceiveovertimeuponachievementofmilestones": 5000000000,
    "transactionpriceallocatedtoremainingperformanceobligations": 1100000,
    "unutilisedfundsofresearchplan": 1400000,
    "explanationofwhenentityexpectstorecognisetransactionpriceallocatedtoremainingperformanceobligationsasrevenue": "The remaining contract liability of €1.1 million is expected to be recognized as revenue with €0.6 million (2022: €9.2 million) over the next 12 months and €0.5 million thereafter (2022: €1.1 million).",
    "revenuefromcontractswithcustomers": 7765000,
    "contractliabilities": 1083000,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -942000,
    "revenuefromgovernmentgrants": 220000,
    "incomefromresearchcollaborations": 1019000,
    "wagesandsalaries": 21972000,
    "socialsecuritycontributions": 3002000,
    "terminationbenefitsexpense": 2134000,
    "employeebenefitsexpense": 27108000,
    "employercontributions": 1272000,
    "deferredtaxliabilities": 2398000,
    "deferredtaxassets": 317000,
    "applicabletaxrate": 0.29825,
    "operatinglosscarryforwardsforcorporateincometaxpurposes": 471700000,
    "operatinglosscarryforwardsfortradetaxpurposes": 470600000,
    "maximumtaxlossduetoownershipchanges": 59000000,
    "taxexpenseincomeatapplicabletaxrate": -31595000,
    "deferredtaxexpenseincome": 29533000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1940000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 125000,
    "numberofpotentialordinarysharesthatareantidilutiveinperiodpresented": 2475013,
    "ifrssharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod": "P3Y",
    "exerciseperiodofshareoptions": "P10Y",
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 822175,
    "fairvalueofshareoptionsatgrantdate": 6000000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 167260,
    "numberofoutstandingshareoptions": 2181888,
    "numberofshareoptionsvestedinsharebasedpaymentarrangement": 1240852,
    "exercisepriceofoutstandingshareoptions2019": 3.5,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P7Y3M18D",
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 35.7,
    "expectedunvestedshareoptionsforfeiturerate": 0.04,
    "numberofoptionscancelled": 20000,
    "weightedaverageshareprice2019": 10.4,
    "expensefromsharebasedpaymenttransactionswithemployees": 10714000,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 7.8,
    "exercisepriceshareoptionsgranted2019": 10.4,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9,
    "descriptionofoptionlifeshareoptionsgranted": 5.9,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0395,
    "amortisationintangibleassetsotherthangoodwill": 33000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 32000,
    "depreciationpropertyplantandequipment": 2000,
    "disposalspropertyplantandequipment": 37000,
    "decreasethroughlossofcontrolofsubsidiarypropertyplantandequipment": 17000,
    "currentfinancialassets": 33500000,
    "interestincomeonfinancialassetsdesignatedatfairvaluethroughprofitorloss": 500000,
    "balanceswithbanks": 26629000,
    "calldeposits": 11900000,
    "valueaddedtaxreceivables": 871000,
    "considerationreceivableforsaleofabcheck": 3100000,
    "currentprepaymentforservicesofmanagingclinicaltrials": 3400000,
    "currentstartupfeeprepaymentsforservicesassociatedwithclinicaltrial": 900000,
    "numberofsharesoutstanding": 14998804,
    "parvaluepershare": 0.1,
    "numberofsharesissued": 60000,
    "authorizedcapital": 3120000,
    "numberofsharesauthorised": 31195000,
    "financialliabilitiesatfairvalue": 12200000,
    "percentageofownershipinterestwithwhichloaniscollateralized": 1,
    "tradeandotherreceivables": 5327000,
    "financialassetspledgedascollateralforliabilitiesorcontingentliabilities": 83618000,
    "liabilitiesarisingfromfinancingactivities": 12152000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": 11688000,
    "borrowingcostcapitalised": 504000,
    "increasedecreasethroughobtainingorlosingcontrolofsubsidiariesorotherbusinessesliabilitiesarisingfromfinancingactivities": -40000,
    "tradeandotherpayables": 16555000,
    "otherpayables": 2307000,
    "ifrssettlementtermforotherpayables": "P30D",
    "ifrslesseeleasingarrangementsoperatingleasestermofcontract": "P10Y",
    "additionstorightofuseassets": 8313000,
    "additionsofnewleasecontracts": 7241000,
    "ifrstermofleasecancellationoption": "P5Y",
    "lesseeoperatingleaseextensionterm": "P5Y",
    "depreciationrightofuseassets": 705000,
    "rightofuseassetsdisposalofsubsidiary": 115000,
    "interestexpenseonleaseliabilities": 87000,
    "ifrsshorttermleasepayments": 19000,
    "cashoutflowforleases": 597000,
    "grossleaseliabilities": 1377000,
    "leaseliabilities": 7199000,
    "leaseliabilitiesdisposalofsubsidiary": 123000,
    "totalleaseliabilitiesotherchanges": 7118000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3256000,
    "keymanagementpersonnelcompensationsharebasedpayment": 4458000,
    "keymanagementpersonnelcompensationterminationbenefits": 1034000,
    "keymanagementpersonnelcompensation": 8748000,
    "remunerationpayabletokeymanagementpersonnelandsupervisorydirectors": 21000,
    "keymanagementpersonnelcompensationforservices": 482000,
    "maximumexposuretocreditrisk": 78200000,
    "interestrevenueexpense": 2276000,
    "financialassetsatfairvalue": 33500000,
    "maximumexposuretoforeigncurrencyrisk": 28533000,
    "percentageofdeviationbetweencurrencyexchangerate": 0.1,
    "netlossincaseofcurrencyexchangedeviation": 1576000,
    "averageforeignexchangerate": 0.04166,
    "closingforeignexchangerate": 0.04045,
    "contractualmaturitiesofborrowings": 5833000
  },
  {
    "date": "2017-12-31",
    "symbol": "AFMD",
    "period": "FY",
    "entityregistrantname": "Affimed N.V.",
    "entitycentralindexkey": 1608390,
    "documenttype": "20-F",
    "documentperiodenddate": "2017-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycommonstocksharesoutstanding": 46791352,
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2017,
    "revenue": 694000,
    "otherincome": 205000,
    "researchanddevelopmentexpense": 1013000,
    "sellinggeneralandadministrativeexpense": 1945000,
    "profitlossfromoperatingactivities": -27260000,
    "financeincome": 8000,
    "profitlossbeforetax": -30243000,
    "incometaxexpensecontinuingoperations": -20000,
    "profitloss": -30223000,
    "comprehensiveincome": -30223000,
    "basicanddilutedearningslosspershare": -0.69,
    "intangibleassetsotherthangoodwill": 65000,
    "propertyplantandequipment": 891000,
    "noncurrentassets": 221000,
    "inventories": 219000,
    "tradeandothercurrentreceivables": 328000,
    "otherassets": 292000,
    "cashandcashequivalents": 38726000,
    "currentassets": 41980000,
    "assets": 43158000,
    "issuedcapital": 468000,
    "otherreserves": 213778000,
    "retainedearnings": -182667000,
    "equity": -182667000,
    "longtermborrowings": 4086000,
    "noncurrentliabilities": 4086000,
    "tradeandothercurrentpayables": 4180000,
    "borrowings": 3083000,
    "deferredincomeclassifiedascurrent": 230000,
    "currentliabilities": 7493000,
    "equityandliabilities": 43158000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -20000,
    "adjustmentsfordepreciationandamortisationexpense": 351000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": -19000,
    "adjustmentsforsharebasedpayments": 1943000,
    "adjustmentsforfinanceincomecost": 2983000,
    "adjustmentstoreconcileprofitlossotherthanchangesinworkingcapital": -24985000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 1140000,
    "adjustmentsfordecreaseincreaseininventories": -44000,
    "adjustmentsfordecreaseincreaseinotherassets": -399000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -1018000,
    "cashflowsfromusedinoperations": -25306000,
    "interestreceivedclassifiedasoperatingactivities": 106000,
    "interestpaidclassifiedasoperatingactivities": 349000,
    "cashflowsfromusedinoperatingactivities": -25549000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 43000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 625000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 35000,
    "purchaseofinvestmentsotherthaninvestmentsaccountedforusingequitymethod": 296000,
    "purchaseofavailableforsalefinancialassets": 13084000,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 22063000,
    "cashflowsfromusedininvestingactivities": 8050000,
    "proceedsfromissueofordinaryshares": 23123000,
    "shareissuerelatedcost": -1648000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 2500000,
    "borrowingcostsrecognisedasexpense": -11000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 167000,
    "cashflowsfromusedinfinancingactivities": 23797000,
    "effectofexchangeratechangesoncashandcashequivalents": -1867000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 6297000,
    "issueofequity": 20922000,
    "increasedecreasethroughsharebasedpaymenttransactions": 1943000,
    "issueofconvertibleinstruments": 51000,
    "titleofnewifrs": "Annual Improvements to IFRS Standards 2015-2017 Cycle",
    "dateasatwhichentityplanstoapplynewifrsinitially": "2019-01-01",
    "revenuefromrenderingofservices": 1600000,
    "revenuefromgovernmentgrants": 195000,
    "wagesandsalaries": 7475000,
    "socialsecuritycontributions": 931000,
    "employeebenefitsexpense": 8406000,
    "employercontributions": 438000,
    "taxexpenseincomeatapplicabletaxrate": 9020000,
    "taxeffectduetoimpairmentofdeferredtaxassets": -9036000,
    "taxeffectofpermanentdifferences": -93000,
    "taxeffectoflocaltaxrates": 195000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 16000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -82000,
    "deferredtaxliabilities": 152000,
    "deferredtaxassets": 405000,
    "operatinglosscarryforwardsforcorporateincometaxpurposes": 146800000,
    "operatinglosscarryforwardsfortradetaxpurposes": 146400000,
    "tradereceivables": 580000,
    "overduetradereceivables": 260000,
    "otherreceivables": 186000,
    "numberofsharesoutstanding": 46791352,
    "parvaluepershare": 0.01,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 1.1,
    "weightedaverageshareprice": 2,
    "exercisepriceshareoptionsgranted": 2.03,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.7,
    "descriptionofoptionlifeshareoptionsgranted": 5.9,
    "descriptionofriskfreeinterestrateshareoptionsgranted": -0.0023,
    "numberofinstrumentsotherequityinstrumentsgranted": 1436075,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 399552,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 4080868,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 2001264,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions": 8.4,
    "expensefromsharebasedpaymenttransactionswithemployees": 144000,
    "financialassetspledgedascollateralforliabilitiesorcontingentliabilities": 40457000,
    "othercurrentpayables": 3083000,
    "tradeandotherpayables": 3380000,
    "otherpayables": 514000,
    "weightedaverageshares": 43746073,
    "minimumleasepaymentspayableundernoncancellableoperatinglease": 363000,
    "leaseandsubleasepaymentsrecognisedasexpense": 472000,
    "otherfeeandcommissionexpense": 174000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1538000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1379000,
    "keymanagementpersonnelcompensation": 10000,
    "keymanagementpersonnelcompensationforservices": 375000,
    "averageforeignexchangerate": 0.88519,
    "closingforeignexchangerate": 0.83382,
    "convertiblenoteandwarrants": 300000,
    "maximumexposuretocreditrisk": 41200000,
    "maximumexposuretoforeigncurrencyrisk": 18768000
  }
]